Innovative Medicine and Research on COVID-19 (C19): Addressing Potential Ethical, Oversight, and Regulatory Barriers

Responses to two separate but related surveys containing open-ended questions to IRB professionals and researchers in the United States who studied COVID-19 during the spring and summer of 2020. These questions focused on ethical, logistical, and practical challenges to overseeing and performing COVID-related research early in the pandemic.